<!DOCTYPE html>
<html lang="en">
  
<!-- Mirrored from www.allindianpatents.com/patents/254454-stable-injectable-oil-in-water-nanoemulsion by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 11:39:45 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Indian Patents. 254454:STABLE INJECTABLE OIL-IN-WATER NANOEMULSION</title>
    <meta content="authenticity_token" name="csrf-param" />
<meta content="cYcP52B8zyTWKbLwby2YPh9z/gvY/RLjWOwY4YXkiXg=" name="csrf-token" />

    <!-- Le HTML5 shim, for IE6-8 support of HTML elements -->
    <!--[if lt IE 9]>
      <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6.1/html5shiv.js" type="text/javascript"></script>
    <![endif]-->

    <link href="../assets/application-e80cf34975c5b1730c80b2f7170e7d26.css" media="all" rel="stylesheet" type="text/css" />

  </head>
  <body>

    <div class="navbar navbar-fluid-top">
      <div class="navbar-inner">
        <div class="container-fluid">
          <a class="btn btn-navbar" data-target=".nav-collapse" data-toggle="collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </a>
          <a class="brand" href="../index.html">Indian Patents</a>
          <div class="container-fluid nav-collapse">
            <ul class="nav">
              <li><a href="../recently-granted.html">Recently Granted Patents</a></li>
              <li><a href="../recently-published.html">Recently Published Patents</a></li>
            </ul>
            <form id="gform" class="navbar-search pull-right" action="https://www.google.com/search" method="get" target="_blank" onsubmit="document.getElementById('gform').q.value='site:http://www.allindianpatents.com '+document.getElementById('gform').q.value">
                <input type="text" name="q" id="q" class="search-query" placeholder="Search" onclick="this.value=''" autocomplete="off">
            </form>
          </div><!--/.nav-collapse -->
        </div>
      </div>
    </div>

    <div class="container-fluid">
      <div class="row-fluid">
        <div class="span12">

          <style>
          .allindianpatents-top { width: 320px; height: 50px; }
          @media(min-width: 500px) { .allindianpatents-top { width: 468px; height: 60px; } }
          @media(min-width: 800px) { .allindianpatents-top { width: 728px; height: 90px; } }
          </style>
          <center>
          </center>
          
          <div class="row-fluid">
	<div class="span8">

		<table class="table">
			<tr>
				<th>Title of Invention</th>
				<td><h1 style="font-size:large;">STABLE INJECTABLE OIL-IN-WATER NANOEMULSION</h1></td>
			</tr>
			<tr>
				<th>Abstract</th>
				<td>The present invention provides an injectable oil-in-water nanoemulsion having average particle size less than 200nm comprising: water insoluble drugs in the concentration of at least 0.01% w/v; oils selected from one or more vegetable oils such as Soya oil, olive oil; MCT oil or mixture thereof, in a concentration of 1% w/v to 30% w/v; Phospholipid in the concentration of 0.1 to 5% w/v; Pegylated phospholipid in the concentration of 0.01 - 10% w/v; other excipients such as isotonicity agents, buffer, antioxidant, stabilizer.</td>
			</tr>
		</table>

					<style>
					.allindianpatents-post-abstract { width: 320px; height: 50px; }
					@media(min-width: 880px) { .allindianpatents-post-abstract { width: 468px; height: 60px; } }
					@media(min-width: 1267px) { .allindianpatents-post-abstract { width: 728px; height: 90px; } }
					</style>
					<center>
					<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
					<!-- AllIndianPatents-post-abstract -->
					<ins class="adsbygoogle allindianpatents-post-abstract"
					     style="display:inline-block"
					     data-ad-client="ca-pub-7914358224572760"
					     data-ad-slot="9152759240"></ins>
					<script>
					(adsbygoogle = window.adsbygoogle || []).push({});
					</script>					
					</center>

		<table class="table">
			<tr>
				<th>Full Text</th>
				<td>FORM   2<br>
THE PATENTS ACT, 1970<br>
(39 OF 1970)<br>
AND<br>
THE PATENT RULES, 2003<br>
PROVISIONAL SPECIFICATION<br>
(See section 10; rule 13)<br><br><br>
Title of the Invention:<br>
"Stable Injectable oil-in-water Nanoemulsion<br>
Applicants):<br>
(a)       Name<br>
BHARAT SERUMS AND VACCINES LTD.<br><br>
(b)       Nationality<br><br>
An Indian company incorporated under the Companies Act 1956.<br><br><br><br>
(c)       Address<br><br>
17    Floor, Hoechst House, Nariman Point, Munibai - 400 021. Maharashtra, India.<br><br><br><br><br><br>
The present invention relates to oil in water emulsion containing pegylated phospholipid for parenteral adrninistration of taxoid drugs or other water insoluble drugs.<br>
Background and prior art:<br>
Docetaxel is commercially available in the form of an injection concentrate under brand name Taxotere. Taxotere is formulated in polysorbate 80 as solubiliser. Taxotere injection comprises two compartment formulations that require two-step dilution before infusion. The first step involves dilution with content of diluent vial (13% ethanol in water for injection) and the second step involves further dilution with diluents such as Dextrose Injection or normal saline etc. for parenteral administration.<br>
Polysorbate 80 causes severe hypersensitivity reaction and fluid retention, hence patients require pre-medications. Thus the marketed formulation has serious manufacturing, handling and dosing limitations.<br>
Further Polysorbate 80 can not be used with PVC delivery apparatus because of its tendency to leach diethyl hexyl phthalate, which is highly toxic.<br>
To avoid these difficulties of mixing two solution before injection following inventions have been reported-US 5478860 describes a stable micro-emulsion for hydrophobic compounds comprising mixture of oil, phospholipid, pegylated lipids. A typical process comprises adding drug to oil, solubilising pegylated lipid and EPC in chloroform, adding this chloroform solution to oil containing drug, admixing well. Chloroform is removed under vacuum to form a film. Film is hydrated with HEPES buffered saline solution (HBSS) followed by addition separately prepared<br>
-2-<br><br>
EPC vesicles to obtain drug to oil weight ratio 1:15. Then the mixture was passed through microfluidizer to decrease the size below 1 OOnm.<br>
US 2006/0067952A1 describes injectable oil in water emulsion of taxoid drugs, comprising phospholipids and vegetable oils, which has to be diluted with aqueous fluid before administration. However, the emulsion is not a stable product and it is preserved as a lyophilized powder and needs reconstitution before use.<br>
A typical process comprises mixing drug, soya oil, MCT oil, egg lecithin and sufficient amount of ethanol to form clear solution. The solution is dried under vacuum until residual ethanol is less than 2.0% by weight. Aqueous phase is prepared by dissolving glycerin and glycine in water and aqueous phase as added to oil phase under higher shear mixer to obtain crude emulsion. pH was adjusted to about 6.5 and the emulsion is passed through microfluidiser and the resulting emulsion is filtered through sterile 0.2u filter.<br>
However, US 2006/0067952Al dose not give a stable product therefore lyophilisation and reconstitution is required before use.<br>
WO2008/042841A2 describes pre-concentrate composition comprising docetaxel containing co-solvent like ethanol and propylene glycol phospholipids, and pegylated phospholipids, suitable for parenteral administration to treat neoplasm conditions upon dilution with aqueous fluids. This pre-concentrate is a non¬aqueous solution and forms emulsion on dilution. However when used in larger doses it is harmful due to toxicity of solvents such as ethanol.<br>
WO2008/042841A2 contains co-solvent which is harmful when given in larger doses.<br>
-3-<br><br>
Object of Invention:<br>
Object of the present invention is to make formulation which is devoid of hypersensitivity reaction and fluid retention there-by avoiding pre-medications. Another object of the present invention is to avoid co-solvents like ethanol in the formulation thereby eliminating adverse effects causes by the cosolvents.<br>
Yet another object of the present invention is to develop a process to make a stable liquid emulsion so that lyophilisation and reconstitution before administration is avoided.<br>
Summary of the Invention:<br>
Accordingly, the present invention provides an injectable oil-in-water nanoemulsion having average particle size less than 200nm comprising: water insoluble drugs in the concentration of at least 0.01% w/v; oils selected from one or more vegetable oils such as Soya oil, olive oil; MCT oil or mixture thereof, in a concentration of 1% w/v to 30% w/v; Phospholipid in the concentration of 0.1 to 5% w/v; Pegylated phospholipid in the concentration of 0.01 - 10% w/v; other excipients such as isotonicity agents, buffer, antioxidant, stabilizer.<br>
In another embodiment of the present invention the process for manufacturing of the above composition comprises following steps, solubilising or dispersing the drug in the oil phase at a temperature of 60 - 70°C; dispersing Phospholipids, Pegylated phospholipid and other excipients in aqueous phase; transferring oil phase to aqueous phase under stirring to form coarse emulsion; homogenization of coarse emulsion to get globule size below 200nm; sterilization of Emulsion by filtration through 0.2u. sterilizing grade filter under aseptic conditions.<br>
-4-<br><br>
Detail description of the invention:<br>
1. Nanoemulsion - The definition of emulsions by the International Union of Pure and Applied Chemistry (IUPAC) states: "In an emulsion, liquid droplets and/or liquid crystals are dispersed in a liquid". Obviously, microemulsions are excluded from this definition if the word "dispersed" is interpreted as non-equilibrium and opposite to "solubilized", term that can be applied to microemulsions and micellar systems. Therefore, there is a fundamental difference between microemulsions and nano-emulsions. Microemulsions are equilibrium systems (i.e. thermodynamically stable), while nano-emulsions are non-equilibrium system with a spontaneous tendency to separate into the constituent phases.<br>
According to this invention Nano-emulsions are emulsions (non-equilibrium systems) with a small droplet size (in the nanometer range, e.g. 20-200 nm).<br>
Nanoemulsions are not to be mistaken with the classic "microemulsions", which are thermodynamically stable and are often referred to as "self-emulsifying systems". Microemulsions are formed when the surface tension is reduced to nearly zero and is only achieved by particular surfactants, combinations or particular packing of the adsorbed layer with surfactant and co-surfactant. These exhibit a very low viscosity and basically comprise swollen micelles with solubilized oil (and drugs). Microemulsion systems are transparent (optically isotropic), but upon dilution they can form conventional emulsion systems<br>
Oil includes vegetable oils &amp; medium chain triglycerides (MCT's). For examples vegetable oil includes, but are not limited to soyabean oil, corn oil, safflower oil, olive oil, etc. vegetable oils are typically long chain triglyceride (usually 14 to about 22 carbons in length).<br>
-5-<br><br>
MCT oil either can naturally derived or synthetic. MCT are made from free fatty acid usually about 8 to about 12 carbon lengths. Representatives are commercially available as "Miglyol 840, MIGLYOL 812, CRODAMOL GTCC-PN, NEOBEE M-5 oil.<br>
The amount of oil, by weight, generally used in this invention of about 3% to about 7%.<br>
Suitable emulsifier includes phospholipids. Phospholipids are trimester of glycerol with two fatty acid &amp; one phosphate ion. Examples of Phospholipids includes but not limited to phosphatidylcholine, lecithin, and more &amp; mixture of phospholipids.<br>
The amount of oil, by weight, generally used in this invention of about 1% to about 3%.<br>
The ratio of oil to phospholipids in the nanoemulsion of the present invention is from about 7:1 to about 1:1 (w/w).<br>
A phospholipid -PEG conjugate for this invention is PEG-phosphatidyl ethanolamine. The PEG chain in such phospholipid preferable has molecular weight in the range of 2000 to 5000. Preferred ratio of pegylated phospholipid to non-pegylated phospholipids used in the invention is about 1:1 to about 1:3 on weight basis.<br>
The composition of present invention may optionally contain additives such as acidifier, alkalinizer, buffer, stabilizer, tonicity modifying agents and other biocompatible materials. Such agents are generally present in aqueous phase of emulsion which helps in stabilizing the emulsion.<br>
.£. .<br><br>
Examples of acidifier but are not limited to hydrochloric acid, citric acid, acetic acid, etc.<br>
Examples of alkalinniser includes sodium hydroxide, sodium citrate etc.<br>
Other biocompatibles materials includes but are not limited to sucrose, mannitol, trehalose, albumin, sorbitol, glecerol, glycine etc.<br>
EXAMPLES:<br>
The invention will now be illustrated with the help of examples.<br>
Examples are for illustrations purpose only and do not restrict the scope the invention.<br>
Example 1:<br>
Equipments used<br>
Water bath. Ultra Turrax IKA stirrer, Niro Saovi Homogenize!.<br>
Formula<br><br>
Ingredients	Quantity<br>
Docetaxel trihydrate	214.0 mg<br>
MCT oil	10.0 gm<br>
Egg Lecithin	2.4 gm<br>
DSPE PEG 2000	1.0 gm<br>
Glycerol	4.50 gm<br>
Water For injection	q.s to 200 ml<br>
0.05NHC1 Solution	q.s to adjust the pH<br>
-7-<br><br>
Procedure<br>
Oil phase:<br>
1.        Required Quantity of Docetaxel Trihydrate weighed in required quantity of MCT oil.<br>
2.	Sonicated above mixture for 10 min and heated to get clear oily colorless<br>
liquid.<br>
Aqueous Phase<br>
3.	Weighed quantity of Glycerol was mixed with required quantity of Water For injection at Room Temperature (20°C±5°C).<br>
4.	Required quantity of DSPE PEG-2000 was solubilized in above solution obtained in Step 3.<br>
5.	Required quantity of Egg Lecithin is then dispersed in the aqueous solution obtained at Step 4.<br>
Coarse Emulsion<br>
6.	Oily phase is transferred to aqueous phase under high speed stirring (on<br>
Ultra Turax IKA stirrer) to obtain coarse emulsion.<br>
Homogenization<br>
7.	Coarse  emulsion obtained  was  immediately  homogenized  at higher<br>
pressure to get desired particle size distribution.<br>
-8-<br><br>
8.	Adjusted the pH of above emulsion.<br>
9.	Emulsion is then filtered through 0.2u filter, filled in vials and sealed under nitrogen purging.<br>
Example 2:<br>
Composition and process is same as Example 1 except that in Example 2 DSPE PEG-2000 was not used and homogenization is carried at higher pressure for longer period.<br>
Table 1 -Observations of Example 1, Example 2, Example 6, Example 9, Example 10<br><br>
		Results<br>
Tests	Example 1	Example<br>
2	Example 6	Example 8	Example 9	Example 10<br>
Appearance	White<br>
Opaque<br>
Liquid	White<br>
Opaque<br>
Liquid	White<br>
Opaque<br>
Liquid	White<br>
Opaque<br>
Liquid	White<br>
Opaque<br>
Liquid	White<br>
Opaque<br>
Liquid<br>
pH	Aq. Phase	5.65	6.33	6.59	6.69	7.8	6.6<br><br>
	Coarse	5.82	5.98	6.11	7.01	7.2	6.15<br><br>
	Final<br>
Homogenisation	5.68	5.96	6.08	6.64	6.34	5.79<br><br>
	After            pH adjustment	4.88	4.63	4.94	4.50	4.68	4.75<br>
Particle<br>
Size<br>
(nm)	Coarse	212.0	283.4	164.7	201.6	180.0	256.2<br><br>
	Final Homogenisation	95.9	142.2	94.8	101.8	99.0	106.8<br><br>
	After            pH adjustment	99.2	140.7	93.0	102.4	99.7	104.1<br>
-9-<br><br>
Stability Result:<br><br>
Example<br>
No.	Time	Temperature Conditions<br><br><br>
	2-8°C	25°C	40°C<br>
1	Initial	White Opaque Liquid	White Opaque Liquid	White Opaque Liquid<br><br>
	24 hrs	White Opaque Liquid	White Opaque Liquid	White Opaque Liquid<br>
2	Initial	White Opaque Liquid	White Opaque Liquid	White Opaque Liquid<br><br>
	24 hrs	White   opaque   liquid with settling of drug	White   opaque   liquid with settling of drug	White   opaque    liquid with settling of drug<br>
6	Initial	White Opaque Liquid	White Opaque Liquid	White Opaque Liquid<br><br>
	24 hrs	White Opaque Liquid	White Opaque Liquid	White Opaque Liquid<br>
8	Initial	White Opaque Liquid	White Opaque Liquid	White Opaque Liquid<br><br>
	24 hrs	White Opaque Liquid	White Opaque Liquid	White Opaque Liquid<br>
9	Initial.	White Opaque Liquid	White Opaque Liquid	White Opaque Liquid<br><br>
	24 hrs	White   opaque   liquid with settling of drug	White   opaque    liquid with settling of drug	White   opaque   liquid with settling of drug<br>
10	Initial	White Opaque Liquid	White Opaque Liquid	White Opaque Liquid<br><br>
	24 hrs	White Opaque Liquid	White Opaque Liquid	White Opaque Liquid<br>
Conclusion<br>
With increasing homogenization time for emulsion without pegylated phospholipids it is not possible to reduce the average particle size below 140nm.<br>
Emulsion without pegylated phospholipids shows settling of drug after 24hrs where as emulsion product prepared incorporating pegylated phospholipids dose not show any settling of drug at all storage conditions studied.<br>
Example 3: Acute Toxicity Study for composition product of Example 1<br>
A)       Single dose Acute Toxicity in Mice<br>
Animal	:	Mice<br>
Species	:	Swiss albino<br>
No. of animals per group	:	10<br>
Dose	:	150mg/kg<br>
-10-<br><br>
Sample	% mortality after 14 days<br>
Example 1	50%<br>
Taxotere	100%<br>
B)        Single Dose Acute Toxicity in Rat<br><br>
Sample	Mortality<br><br>
	l0mg/kg	30mg/kg	50mg/kg<br>
Example 1	0/6	0/6	2/6<br>
Taxotere	0/6	2/6	5/6<br>
Example 4: Toxicity study for composition product of Example 1<br><br>
Animal<br>
Species<br>
Dose<br>
Dosage schedule<br><br>
Mice<br>
Swiss albino 10,22, 33, 50mg/kg q4d X 3 (0, 4, 8 days)<br><br><br>
Sample	Dose	% mortality after 14 days<br>
Example 1	l0 mg/kg	0%<br><br>
	22 mg/kg	0%<br><br>
	33 mg/kg	0%<br><br>
	50 mg/kg	40%<br>
Taxotere	l0 mg/kg	0%<br><br>
	22 mg/kg	10%<br><br>
	33 mg/kg	20%<br><br>
	50mg/kg	70%<br>
Example 5: Comparative Single dose pharmacokinetic in Rat<br>
Composition of Example 1 is used and Taxotere is used as a comparator.<br><br>
Animal	:     Rat<br>
Species	:     Wistar<br>
Dose	:     l0mg/kg<br>
-11 -<br><br>
Time (hrs)	Plasma concentration (ng/mL)<br><br>
	Taxotere	Example 1<br>
0.083	1374.15	4070.84<br>
0.5	445.41	564.21<br>
4	166.29	221.33<br>
8	59.11	191.82<br>
24	68.49	53.74<br>
Cmax and AUC with composition of Example 1 were found to be higher than that obtained with Taxotere.<br>
Example 6:<br>
The process and quantities of excipients are same as Example 1 except in stead of Docetaxel trihydrate, Docetaxel anhydrous was used.<br>
Observations and stability results are given in Table 1.<br>
Conclusion<br>
This example shows emulsion with docetaxel anhydrous shows similar stability profile as docetaxel trihydrate.<br>
Example 7: In-vitro Plasma Study of products of Example 1 and Example 2<br>
Procedure<br>
1.	0.2 ml of Docetaxel emulsion mixed in 0.9 ml of Human plasma in eppendorff tube.<br>
2.	Particle size of mixture is analyzed.<br>
3.	The mixed sample is incubated at 37°C for 24 hr.<br>
4.	Particle size of incubated sample is analyzed.<br>
-12-<br><br>
Observations<br><br>
Example No.	Initial particle size	After Incubation at 37°C for 24 Hr<br>
Example 1	105.1 nm	106.2 nm<br><br>
	105.1nm	103.9 nm<br>
Example 2	140 nm	1.32micron<br><br>
	140 nm	1.47micron<br>
Nanoemulsion prepared with pegylated phospholipid is stable in plasma where as emulsion prepared without pegylated phospholipid is not physically stable.<br>
Example 8: Nanoemulsion prepared using mixture of vegetable oil and MCT oil<br>
Equipments used<br>
Water bath, Ultra Turrax IKA stirrer, Niro Saovi Homogenizer.<br>
Formula<br><br>
Ingredients	Quantity<br>
Docetaxel trihydrate	107'mg<br>
MCT oil	2.5 gm<br>
Soya Oil	2.5 gm<br>
Egg Lecithin	1.2 gm<br>
DSPE PEG 2000	500mg<br>
Glycerol	2.25 gm<br>
Water For injection	q.s to l00 ml<br>
0.05N HC1 Solution	q.s to adjust pH<br>
Procedure<br>
Same as Example 1<br>
Observations and stability results are given in Table 1.<br>
-13-<br><br>
Example 9 - Prepared as per US 2006\0067952Al<br>
Equipments used<br>
Water bath, Ultra Turrax IKA stirrer, Niro Saovi Homogenizer.<br><br>
Ingredients	Qty/Batch<br>
Docetaxel Trihydrate	53.5' mg<br>
MCT oil	1.5gm<br>
Soya oil	1.5 gm<br>
Ethanol	2.0 ml<br>
Egg Lecithin	3.1 gm<br>
Glycine	50 mg<br>
Glycerol	2.25 gm<br>
Water For injection	q.sto 100 ml<br>
0.05N HCI Solution	q.s to adjust pH<br>
Procedure<br>
Same as Example 1<br>
Observations and stability results are given in Table 1.<br>
This example shows the essentiality of pegylated phospholipids for the stability of<br>
the formulation.<br>
Example 10 - Formulation prepared with DPPC as surfactant instead of egg<br>
lecithin<br>
Equipments used<br>
Water bath, Ultra Turrax IKA stirrer, Niro Saovi Homogenizer.<br><br>
Ingredients	Qty/Batch<br>
Docetaxel Trihydrate	108.0Tmg<br>
MCT oil	5.0 gm<br>
DPPC	1.0 gm<br>
DSPE PEG 2000	1.0 gm<br>
Glycerol	2.25 gm<br>
Water For injection	q.sto 100 ml<br>
0.05N HCI Solution	q.s to adjust pH<br>
-14-<br><br>
Procedure<br>
Same as Example 1<br>
Instead of egg lecithin DPPC was dispersed in aqueous phase.<br>
Observations and stability results are given in Table 1.<br>
Advantages of the invention:<br>
1.	The compositions of the present invention are free from ethanol and<br>
surfactant Polysorbate-80. Therefore composition of present invention is<br>
devoid of hypersensitivity reaction and fluid retention characteristics of<br>
these ingredients.<br>
2.	No pre-medication required to overcome hypersensitivity reactions<br>
experienced with currently marketed preparation.<br>
3.	Shows higher Cmax and AUC may lead to better efficacy at equivalent<br>
doses or if the dosage is reduced then it may lead to less toxic effects of<br>
the drug.<br>
4.	The process of preparation is free from any solvent and co-solvent like<br>
ethanol, propylene glycol and chloroform.<br>
5.	Process gives stable nanoemulsion which gives Enhanced Permeability<br>
Retention (EPR) effect.<br>
Dated this   17th day of July 2008.<br><br>
To<br>
The Controller of Patents,<br>
The Patent Office,<br>
At Mumbai.<br>
- 15-<br></td>
			</tr>
		</table>	
		<br>
		<h3>Documents:</h3>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1NVU0tMjAwOC1BQlNUUkFDVCAoMjQtOC0yMDEyKS5wZGY=" target="_blank" style="word-wrap:break-word;">1565-MUM-2008-ABSTRACT (24-8-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1tdW0tMjAwOC1hYnN0cmFjdCgyMi03LTIwMDkpLnBkZg==" target="_blank" style="word-wrap:break-word;">1565-mum-2008-abstract(22-7-2009).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1NVU0tMjAwOC1BQlNUUkFDVCgyNC04LTIwMTIpLnBkZg==" target="_blank" style="word-wrap:break-word;">1565-MUM-2008-ABSTRACT(24-8-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1NVU0tMjAwOC1BQlNUUkFDVCgyNC05LTIwMTIpLnBkZg==" target="_blank" style="word-wrap:break-word;">1565-MUM-2008-ABSTRACT(24-9-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1NVU0tMjAwOC1BQlNUUkFDVChHUkFOVEVEKS0oNi0xMS0yMDEyKS5wZGY=" target="_blank" style="word-wrap:break-word;">1565-MUM-2008-ABSTRACT(GRANTED)-(6-11-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1NVU0tMjAwOC1BTk5FWFVSRSBBKDI0LTgtMjAxMikucGRm" target="_blank" style="word-wrap:break-word;">1565-MUM-2008-ANNEXURE A(24-8-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1NVU0tMjAwOC1BTk5FWFVSRSBCKDI0LTgtMjAxMikucGRm" target="_blank" style="word-wrap:break-word;">1565-MUM-2008-ANNEXURE B(24-8-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1NVU0tMjAwOC1BTk5FWFVSRSBUTyBGT1JNIDMoMjEtMS0yMDExKS5wZGY=" target="_blank" style="word-wrap:break-word;">1565-MUM-2008-ANNEXURE TO FORM 3(21-1-2011).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1NVU0tMjAwOC1BTk5FWFVSRSBUTyBGT1JNIDMoMjQtOC0yMDEyKS5wZGY=" target="_blank" style="word-wrap:break-word;">1565-MUM-2008-ANNEXURE TO FORM 3(24-8-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1NVU0tMjAwOC1BTk5FWFVSRSBUTyBGT1JNIDMoMzAtMTEtMjAxMSkucGRm" target="_blank" style="word-wrap:break-word;">1565-MUM-2008-ANNEXURE TO FORM 3(30-11-2011).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1NVU0tMjAwOC1DQU5DRUxMRUQgUEFHRVMoMjQtOC0yMDEyKS5wZGY=" target="_blank" style="word-wrap:break-word;">1565-MUM-2008-CANCELLED PAGES(24-8-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1tdW0tMjAwOC1jbGFpbXMoMjItNy0yMDA5KS5wZGY=" target="_blank" style="word-wrap:break-word;">1565-mum-2008-claims(22-7-2009).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1NVU0tMjAwOC1DTEFJTVMoQU1FTkRFRCkgLSgyNC04LTIwMTIpLnBkZg==" target="_blank" style="word-wrap:break-word;">1565-MUM-2008-CLAIMS(AMENDED) -(24-8-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1NVU0tMjAwOC1DTEFJTVMoQU1FTkRFRCktKDI0LTgtMjAxMikucGRm" target="_blank" style="word-wrap:break-word;">1565-MUM-2008-CLAIMS(AMENDED)-(24-8-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1NVU0tMjAwOC1DTEFJTVMoQU1FTkRFRCktKDI0LTktMjAxMikucGRm" target="_blank" style="word-wrap:break-word;">1565-MUM-2008-CLAIMS(AMENDED)-(24-9-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1NVU0tMjAwOC1DTEFJTVMoR1JBTlRFRCktKDYtMTEtMjAxMikucGRm" target="_blank" style="word-wrap:break-word;">1565-MUM-2008-CLAIMS(GRANTED)-(6-11-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1NVU0tMjAwOC1DTEFJTVMoTUFSS0VEIENPUFkpLSgyNC05LTIwMTIpLnBkZg==" target="_blank" style="word-wrap:break-word;">1565-MUM-2008-CLAIMS(MARKED COPY)-(24-9-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1NVU0tMjAwOC1DT1JSRVNQT05ERU5DRSgyMS0xLTIwMTApLnBkZg==" target="_blank" style="word-wrap:break-word;">1565-MUM-2008-CORRESPONDENCE(21-1-2010).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1NVU0tMjAwOC1DT1JSRVNQT05ERU5DRSgyMS0xLTIwMTEpLnBkZg==" target="_blank" style="word-wrap:break-word;">1565-MUM-2008-CORRESPONDENCE(21-1-2011).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1tdW0tMjAwOC1jb3JyZXNwb25kZW5jZSgyMi03LTIwMDkpLnBkZg==" target="_blank" style="word-wrap:break-word;">1565-mum-2008-correspondence(22-7-2009).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1NVU0tMjAwOC1DT1JSRVNQT05ERU5DRSgyOC0xLTIwMTApLnBkZg==" target="_blank" style="word-wrap:break-word;">1565-MUM-2008-CORRESPONDENCE(28-1-2010).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1NVU0tMjAwOC1DT1JSRVNQT05ERU5DRSgzMC0xMS0yMDExKS5wZGY=" target="_blank" style="word-wrap:break-word;">1565-MUM-2008-CORRESPONDENCE(30-11-2011).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1NVU0tMjAwOC1DT1JSRVNQT05ERU5DRShJUE8pLSg2LTExLTIwMTIpLnBkZg==" target="_blank" style="word-wrap:break-word;">1565-MUM-2008-CORRESPONDENCE(IPO)-(6-11-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1tdW0tMjAwOC1jb3JyZXNwb25kZW5jZS5wZGY=" target="_blank" style="word-wrap:break-word;">1565-mum-2008-correspondence.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1tdW0tMjAwOC1kZXNjcmlwdGlvbihjb21wbGV0ZSktKDIyLTctMjAwOSkucGRm" target="_blank" style="word-wrap:break-word;">1565-mum-2008-description(complete)-(22-7-2009).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1NVU0tMjAwOC1ERVNDUklQVElPTihHUkFOVEVEKS0oNi0xMS0yMDEyKS5wZGY=" target="_blank" style="word-wrap:break-word;">1565-MUM-2008-DESCRIPTION(GRANTED)-(6-11-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1tdW0tMjAwOC1kZXNjcmlwdGlvbihwcm92aXNpb25hbCkuZG9j" target="_blank" style="word-wrap:break-word;">1565-mum-2008-description(provisional).doc</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1tdW0tMjAwOC1kZXNjcmlwdGlvbihwcm92aXNpb25hbCkucGRm" target="_blank" style="word-wrap:break-word;">1565-mum-2008-description(provisional).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1tdW0tMjAwOC1mb3JtIDEucGRm" target="_blank" style="word-wrap:break-word;">1565-mum-2008-form 1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1tdW0tMjAwOC1mb3JtIDE4KDIyLTctMjAwOSkucGRm" target="_blank" style="word-wrap:break-word;">1565-mum-2008-form 18(22-7-2009).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1tdW0tMjAwOC1mb3JtIDIoMjItNy0yMDA5KS5wZGY=" target="_blank" style="word-wrap:break-word;">1565-mum-2008-form 2(22-7-2009).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1NVU0tMjAwOC1GT1JNIDIoR1JBTlRFRCktKDYtMTEtMjAxMikucGRm" target="_blank" style="word-wrap:break-word;">1565-MUM-2008-FORM 2(GRANTED)-(6-11-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1tdW0tMjAwOC1mb3JtIDIodGl0bGUgcGFnZSktKDIyLTctMjAwOSkucGRm" target="_blank" style="word-wrap:break-word;">1565-mum-2008-form 2(title page)-(22-7-2009).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1NVU0tMjAwOC1GT1JNIDIoVElUTEUgUEFHRSktKEdSQU5URUQpLSg2LTExLTIwMTIpLnBkZg==" target="_blank" style="word-wrap:break-word;">1565-MUM-2008-FORM 2(TITLE PAGE)-(GRANTED)-(6-11-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1tdW0tMjAwOC1mb3JtIDIodGl0bGUgcGFnZSkucGRm" target="_blank" style="word-wrap:break-word;">1565-mum-2008-form 2(title page).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1tdW0tMjAwOC1mb3JtIDIuZG9j" target="_blank" style="word-wrap:break-word;">1565-mum-2008-form 2.doc</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1tdW0tMjAwOC1mb3JtIDIucGRm" target="_blank" style="word-wrap:break-word;">1565-mum-2008-form 2.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1NVU0tMjAwOC1GT1JNIDMoMjEtMS0yMDEwKS5wZGY=" target="_blank" style="word-wrap:break-word;">1565-MUM-2008-FORM 3(21-1-2010).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1tdW0tMjAwOC1mb3JtIDMoMjItNy0yMDA5KS5wZGY=" target="_blank" style="word-wrap:break-word;">1565-mum-2008-form 3(22-7-2009).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1NVU0tMjAwOC1GT1JNIDMoMjgtMS0yMDEwKS5wZGY=" target="_blank" style="word-wrap:break-word;">1565-MUM-2008-FORM 3(28-1-2010).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1tdW0tMjAwOC1mb3JtIDMucGRm" target="_blank" style="word-wrap:break-word;">1565-mum-2008-form 3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1tdW0tMjAwOC1mb3JtIDUoMjItNy0yMDA5KS5wZGY=" target="_blank" style="word-wrap:break-word;">1565-mum-2008-form 5(22-7-2009).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1NVU0tMjAwOC1GT1JNIFBDVC1JUEVBLTQwOSgyMS0xLTIwMTEpLnBkZg==" target="_blank" style="word-wrap:break-word;">1565-MUM-2008-FORM PCT-IPEA-409(21-1-2011).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1NVU0tMjAwOC1GT1JNIFBDVC1JU0EtMjEwKDIxLTEtMjAxMSkucGRm" target="_blank" style="word-wrap:break-word;">1565-MUM-2008-FORM PCT-ISA-210(21-1-2011).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1tdW0tMjAwOC1nZW5lcmFsIHBvd2VyIG9mIGF0dG9ybmV5KDIyLTctMjAwOSkucGRm" target="_blank" style="word-wrap:break-word;">1565-mum-2008-general power of attorney(22-7-2009).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1NVU0tMjAwOC1HRU5FUkFMIFBPV0VSIE9GIEFUVE9STkVZKDI0LTgtMjAxMikucGRm" target="_blank" style="word-wrap:break-word;">1565-MUM-2008-GENERAL POWER OF ATTORNEY(24-8-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1NVU0tMjAwOC1HRU5FUkFMIFBPV0VSIE9GIEFUVE9STkVZKDMwLTExLTIwMTEpLnBkZg==" target="_blank" style="word-wrap:break-word;">1565-MUM-2008-GENERAL POWER OF ATTORNEY(30-11-2011).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1NVU0tMjAwOC1NQVJLRUQgQ09QWSgyNC04LTIwMTIpLnBkZg==" target="_blank" style="word-wrap:break-word;">1565-MUM-2008-MARKED COPY(24-8-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1NVU0tMjAwOC1PVEhFUiBET0NVTUVOVCgyNC05LTIwMTIpLnBkZg==" target="_blank" style="word-wrap:break-word;">1565-MUM-2008-OTHER DOCUMENT(24-9-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1NVU0tMjAwOC1QRVRJVElPTiBVTkRFUiBSVUxFLTEzNygyNC05LTIwMTIpLnBkZg==" target="_blank" style="word-wrap:break-word;">1565-MUM-2008-PETITION UNDER RULE-137(24-9-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1NVU0tMjAwOC1SRVBMWSBUTyBFWEFNSU5BVElPTiBSRVBPUlQoMjQtOC0yMDEyKS5wZGY=" target="_blank" style="word-wrap:break-word;">1565-MUM-2008-REPLY TO EXAMINATION REPORT(24-8-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1NVU0tMjAwOC1SRVBMWSBUTyBIRUFSSU5HKDI0LTktMjAxMikucGRm" target="_blank" style="word-wrap:break-word;">1565-MUM-2008-REPLY TO HEARING(24-9-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1NVU0tMjAwOC1TUEVDSUZJQ0FUSU9OKEFNRU5ERUQpIC0oMjQtOC0yMDEyKS5wZGY=" target="_blank" style="word-wrap:break-word;">1565-MUM-2008-SPECIFICATION(AMENDED) -(24-8-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1NVU0tMjAwOC1TUEVDSUZJQ0FUSU9OKEFNRU5ERUQpLSgyNC04LTIwMTIpLnBkZg==" target="_blank" style="word-wrap:break-word;">1565-MUM-2008-SPECIFICATION(AMENDED)-(24-8-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU2NS1NVU0tMjAwOC1TUEVDSUZJQ0FUSU9OKEFNRU5ERUQpLSgyNC05LTIwMTIpLnBkZg==" target="_blank" style="word-wrap:break-word;">1565-MUM-2008-SPECIFICATION(AMENDED)-(24-9-2012).pdf</a></p>
		<br>
		<div class="pull-left">
			<a href="254453-sacrificial-anode-assembly.html">&laquo; Previous Patent</a>
		</div>
		<div class="pull-right">
			<a href="254455-scraper-blade-and-method-of-manufacturing-the-same.html">Next Patent &raquo;</a>
		</div>			
	</div><!-- /span8 -->
	<div class="span4">
		<div class="well infobox">
			<table class="table table-condensed">
				<tr>
					<th>Patent Number</th>
					<td>254454</td>
				</tr>
				<tr>
					<th>Indian Patent Application Number</th>
					<td>1565/MUM/2008</td>
				</tr>
				<tr>
					<th>PG Journal Number</th>
					<td>45/2012</td>
				</tr>
				<tr>
					<th>Publication Date</th>
					<td>09-Nov-2012</td>
				</tr>
				<tr>
					<th>Grant Date</th>
					<td>06-Nov-2012</td>
				</tr>
				<tr>
					<th>Date of Filing</th>
					<td>23-Jul-2008</td>
				</tr>
				<tr>
					<th>Name of Patentee</th>
					<td>BHARAT SERUMS AND VACCINES LTD</td>
				</tr>
				<tr>
					<th>Applicant Address</th>
					<td>17TH FLOOR, HOECHST HOUSE, NARIMAN POINT, MUMBAI,</td>
				</tr>
				<tr>
					<td colspan=2>
								<h5>Inventors:</h5>
								<table class="table">
									<tr>
										<th>#</th>
										<th>Inventor's Name</th>
										<th>Inventor's Address</th>
									</tr>

										<tr>
											<td>1</td>
											<td>DAFTARY GAUTAM VINOD</td>
											<td>17TH FLOOR, HOECHST HOUSE, NARIMAN POINT, MUMBAI-400 021,</td>
										</tr>
										<tr>
											<td>2</td>
											<td>PAI SRIKANTH ANNAPPA</td>
											<td>17TH FLOOR, HOECHST HOUSE, NARIMAN POINT, MUMBAI-400 021,</td>
										</tr>
										<tr>
											<td>3</td>
											<td>KULKARNI MANGESH MANIKRAO</td>
											<td>17TH FLOOR, HOECHST HOUSE, NARIMAN POINT, MUMBAI-400 021,</td>
										</tr>
								</table>
					</td>
				</tr>
				<tr>
					<th>PCT International Classification Number</th>
					<td>A61K8/18;A61K8/06</td>
				</tr>
				<tr>
					<th>PCT International Application Number</th>
					<td>N/A</td>
				</tr>
				<tr>
					<th>PCT International Filing date</th>
					<td></td>
				</tr>
				<tr>
					<td colspan=2>
						<h5>PCT Conventions:</h5>
						<table class="table">
							<tr>
								<th>#</th>
								<th>PCT Application Number</th>
								<th>Date of Convention</th>
								<th>Priority Country</th>
							</tr>

								<tr>
									<td>1</td>
									<td></td>
									<td></td>
								    <td>NA</td>
								</tr>

						</table>
					</td>
				</tr>
			</table>
		</div><!-- /well -->
	</div><!-- /span4 -->
</div><!-- /row-fluid -->

        </div>

      </div><!--/row-->

      <footer class="footer">

        <style>
        .allindianpatents-footer { width: 320px; height: 50px; }
        @media(min-width: 500px) { .allindianpatents-footer { width: 468px; height: 60px; } }
        @media(min-width: 800px) { .allindianpatents-footer { width: 728px; height: 90px; } }
        </style>
        <center>
        </center>

        <p>&copy; All Indian Patents, 2013-2021.</p>
        <p>Patent data available in the public domain from Indian Patents Office, Department of Industrial Policy and Promotions, Ministry of Commerce and Industry, Government of India.</p>
      </footer>

    </div> <!-- /container -->

    <!-- Javascripts
    ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="../assets/application-95f297ff0d8d2015987f04b30593c800.js" type="text/javascript"></script>

    <!-- Start of StatCounter Code for Default Guide -->
    <script type="text/javascript">
    var sc_project=8902313; 
    var sc_invisible=1; 
    var sc_security="3c1f8147"; 
    var scJsHost = (("https:" == document.location.protocol) ?
    "https://secure." : "http://www.");
    document.write("<sc"+"ript type='text/javascript' src='" +
    scJsHost+
    "statcounter.com/counter/counter.js'></"+"script>");
    </script>
    <noscript><div class="statcounter"><a title="web stats"
    href="http://statcounter.com/free-web-stats/"
    target="_blank"><img class="statcounter"
    src="http://c.statcounter.com/8902313/0/3c1f8147/1/"
    alt="web stats"></a></div></noscript>
    <!-- End of StatCounter Code for Default Guide -->

    <script>
      (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
      (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
      m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
      })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

      ga('create', 'UA-244143-31', 'allindianpatents.com');
      ga('send', 'pageview');

    </script>

  </body>

<!-- Mirrored from www.allindianpatents.com/patents/254454-stable-injectable-oil-in-water-nanoemulsion by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 11:39:46 GMT -->
</html>
